Aurinia Pharmaceuticals Company Profile (NASDAQ:AUPH)

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals logoAurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN. Voclosporin is an oral drug, administered twice daily. It is structurally similar to cyclosporine A (CsA), but is chemically modified on the amino acid-1 residue. It has completed two Phase III clinical studies in patients with moderate to severe psoriasis. It has completed Phase IIb clinical trial, which is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active LN.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AUPH
  • CUSIP:
Key Metrics:
  • Previous Close: $2.42
  • 50 Day Moving Average: $2.26
  • 200 Day Moving Average: $2.74
  • 52-Week Range: $1.42 - $4.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.33
  • P/E Growth: 0.00
  • Market Cap: $93.16M
  • Outstanding Shares: 35,286,000
  • Beta: 3.17
Profitability:
  • Net Margins: -7,440.71%
  • Return on Equity: -100.63%
  • Return on Assets: -60.99%
Debt:
  • Current Ratio: 3.55%
  • Quick Ratio: 3.55%
Additional Links:
Companies Related to Aurinia Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Aurinia Pharmaceuticals (NASDAQ:AUPH) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.00 (240.91% upside)

Analysts' Ratings History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
Show:
DateFirmActionRatingPrice TargetDetails
8/17/2016HC WainwrightBoost Price TargetBuy$7.00 -> $10.00View Rating Details
8/16/2016Leerink SwannReiterated RatingOutperformView Rating Details
8/15/2016FBR & CoReiterated RatingOutperform$9.00View Rating Details
8/5/2016Canaccord GenuitySet Price TargetBuy$10.00View Rating Details
5/8/2015MLV & Co.Initiated CoverageBuy$9.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/31/2015($0.11)($0.15)ViewN/AView Earnings Details
11/12/2014Q3 14($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aurinia Pharmaceuticals (NASDAQ:AUPH)
Current Year EPS Consensus Estimate: $-0.51 EPS
Next Year EPS Consensus Estimate: $-0.61 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.15)($0.15)($0.15)
Q3 20162($0.15)($0.12)($0.14)
Q4 20162($0.13)($0.12)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Aurinia Pharmaceuticals (NASDAQ:AUPH)
DateHeadline
investingnews.com logoAurinia Announces That Voclosporin Achieves Primary Endpoints (NASDAQ:AUPH)
investingnews.com - September 30 at 8:55 AM
streetinsider.com logoAurinia Pharmaceuticals (AUPH) Says Voclosporin Achieves Primary, Secondary Endpoints in Phase IIb Study for LN (NASDAQ:AUPH)
www.streetinsider.com - September 30 at 8:55 AM
rttnews.com logoAurinia Pharmaceuticals Inc. (AUPH) Is Rising On Phase 2 Study Results (NASDAQ:AUPH)
www.rttnews.com - September 30 at 8:55 AM
finance.yahoo.com logoAurinia Announces That Voclosporin Achieves Primary and All Pre-Specified Secondary Endpoints in Its Phase IIb AURA-LV Study for Lupus Nephritis (LN) (NASDAQ:AUPH)
finance.yahoo.com - September 30 at 8:55 AM
finance.yahoo.com logo4:59 pm Aurinia Pharma announces that voclosporin achieves primary and all pre-specified secondary endpoints in Phase IIb AURA-LV study for Lupus Nephritis -- shares halted (NASDAQ:AUPH)
finance.yahoo.com - September 30 at 8:55 AM
News IconAurinia Pharmaceuticals Inc (AUPH) Updated Broker Price Targets - The De Soto Edge (NASDAQ:AUPH)
desotoedge.com - September 29 at 8:46 AM
News IconAurinia Pharmaceuticals Inc (AUPH) Latest Broker Coverage - NewsDen (NASDAQ:AUPH)
newsden.net - September 28 at 3:47 PM
News IconValuable Price Trends to Observe: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) , Aurinia Pharmaceuticals Inc ... - Wall Street Times (press release) (NASDAQ:AUPH)
www.wallstreetnews24.com - September 28 at 8:26 AM
investornewswire.com logoCan Shares Of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Hit $10? - Investor Newswire (NASDAQ:AUPH)
www.investornewswire.com - September 26 at 3:48 PM
News IconCanadian Companies for Your Trading Radar: Aurinia Pharmaceuticals Inc. (AUPH), Valeant Pharmaceuticals ... - The Independent Republic (NASDAQ:AUPH)
theindependentrepublic.com - September 26 at 3:48 PM
businesswire.com logoAurinia Pharmaceuticals to Present at the Leerink Partners Roundtable Series in New York September 28, 2016 - Business Wire (press release) (NASDAQ:AUPH)
www.businesswire.com - September 24 at 3:36 PM
wallstrt24.com logoVolatile Movements - JetBlue Airways Corporation, (NASDAQ:JBLU), Aurinia Pharmaceuticals, (NASDAQ:AUPH), Visa ... - Wall Street 24 (NASDAQ:AUPH)
wallstrt24.com - September 23 at 4:04 PM
News IconExpert Analysts Sentiments for: The York Water Company (NASDAQ:YORW) , Aurinia Pharmaceuticals Inc (NASDAQ ... - Wall Street Times (press release) (NASDAQ:AUPH)
www.wallstreetnews24.com - September 23 at 8:41 AM
News IconSafe Haven Investment Portfolio Stocks: bluebird bio (BLUE), Aurinia Pharmaceuticals (AUPH), Pier 1 Imports (PIR) - Street Wise Report (press release) (blog) (NASDAQ:AUPH)
streetwisereport.com - September 23 at 8:41 AM
News IconAurinia Pharmaceuticals to Present at the Leerink Partners Roundtable Series in New York ... (NASDAQ:AUPH)
www.biomedreports.com - September 22 at 9:32 AM
finance.yahoo.com logoAurinia Pharmaceuticals to Present at the Leerink Partners Roundtable Series in New York September 28, 2016 (NASDAQ:AUPH)
finance.yahoo.com - September 22 at 9:32 AM
businesswire.com logoAurinia Pharmaceuticals to Host Lupus Nephritis (LN) Breakfast and Webcast on September 30 th in New York (NASDAQ:AUPH)
www.businesswire.com - September 21 at 4:33 PM
News IconAurinia To Host Lupus Nephritis (LN) Breakfast And Webcast On September 30th In New York (NASDAQ:AUPH)
www.biospace.com - September 21 at 4:33 PM
News IconWhat is the Sell-side Saying About Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)? - Frisco Fastball (NASDAQ:AUPH)
friscofastball.com - September 21 at 7:55 AM
investornewswire.com logoShares Of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Expected To Hit $10 - Investor Newswire (NASDAQ:AUPH)
www.investornewswire.com - September 20 at 3:39 PM
News IconAurinia Pharmaceuticals Ord (NASDAQ:AUPH) Shorted Shares Increased By 307.64% - Post News (NASDAQ:AUPH)
www.kentuckypostnews.com - September 15 at 3:51 PM
News IconAnalysts Place Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Under the Lens of the Microscope - Post News (NASDAQ:AUPH)
www.kentuckypostnews.com - September 15 at 12:35 PM
investornewswire.com logoCan Shares Of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Hit $10 - Investor Newswire (NASDAQ:AUPH)
www.investornewswire.com - September 13 at 8:30 AM
News IconWall Street Consensus Opinions for: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) , Bluerock Residential Growth REIT ... - Wall Street Times (press release) (NASDAQ:AUPH)
www.wallstreetnews24.com - September 12 at 8:28 AM
News IconShares Gapping Up Pre-Bell: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Post News (NASDAQ:AUPH)
www.kentuckypostnews.com - September 9 at 3:36 PM
News IconBiotech Stocks To Put On Your Watch List: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Aurinia Pharmaceuticals Inc ... - The Voice Registrar (NASDAQ:AUPH)
voiceregistrar.com - September 8 at 9:34 AM
businesswire.com logoAurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18 th Annual Global Investment Conference - Business Wire (press release) (NASDAQ:AUPH)
www.businesswire.com - September 8 at 9:34 AM
thestreet.com logo5 Stocks Under $10 That Could Make You a Lot of Money (NASDAQ:AUPH)
www.thestreet.com - September 8 at 9:33 AM
seekingalpha.com logoAurinia Pharmaceuticals Share Price Being Unfairly Punished ... - Seeking Alpha (NASDAQ:AUPH)
seekingalpha.com - August 31 at 3:39 PM
News IconCrowd & Street Monitoring Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) - Post News (NASDAQ:AUPH)
www.kentuckypostnews.com - August 25 at 8:29 AM
investornewswire.com logoAurinia Pharmaceuticals Inc (NASDAQ:AUPH) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:AUPH)
www.investornewswire.com - August 22 at 8:45 PM
News IconInvestor's Alert: Aurinia Pharmaceuticals (AUPH), Alimera Sciences (ALIM) - Newburg Press (NASDAQ:AUPH)
newburghpress.com - August 19 at 4:16 PM
News IconAurinia Pharmaceuticals Inc.'s (AUPH): Stock Analysis Review - Hot Stocks Point (NASDAQ:AUPH)
www.hotstockspoint.com - August 18 at 3:49 PM
streetinsider.com logoFBR See Sell Off in Aurinia Pharma (AUPH) as Overdone; Remains Positive on Voclosporin (NASDAQ:AUPH)
www.streetinsider.com - August 17 at 11:51 AM
investornewswire.com logoWill Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Hit $9 Price Target? - Investor Newswire (NASDAQ:AUPH)
www.investornewswire.com - August 16 at 3:42 PM
News IconAurinia Pharmaceuticals (NASDAQ:AUPH) & Avis Budget Group Inc. (NASDAQ:CAR) Active Movers - Money News (press release) (NASDAQ:AUPH)
www.newsismoney.com - August 16 at 3:42 PM
News IconPatient deaths distract the Street from Aurinia promising lupus data (NASDAQ:AUPH)
www.bioworld.com - August 15 at 9:11 PM
benzinga.com logoMid-Afternoon Market Update: Crude Oil Up 2.7%; Providence & Worcester Railroad Shares Spike Higher (NASDAQ:AUPH)
www.benzinga.com - August 15 at 3:44 PM
nasdaq.com logoMid-Day Market Update: Sorl Auto Parts Gains Following Q2 Results; Performance Sports Shares Slide (NASDAQ:AUPH)
www.nasdaq.com - August 15 at 3:44 PM
stockhouse.com logoMid-Morning Market Update: Markets Open Higher; SYSCO Profit Tops Estimates (NASDAQ:AUPH)
www.stockhouse.com - August 15 at 10:52 AM
4-traders.com logoAurinia Pharmaceuticals : Announces Voclosporin Meets Primary Endpoint (NASDAQ:AUPH)
www.4-traders.com - August 15 at 10:52 AM
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH): Our Subscribers Are Already Up A W Whopping 45% In Just 3-Sessuion After Buy Call (NASDAQ:AUPH)
www.marketnewscall.com - August 15 at 10:52 AM
News IconAurinia Pharmaceuticals (AUPH) Plunges Despite Upbeat Trial Data (NASDAQ:AUPH)
www.economiccalendar.com - August 15 at 10:52 AM
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH): We Bought The Stock At $3.24, Now Up Crazy 40% Quickly (NASDAQ:AUPH)
www.marketnewscall.com - August 11 at 9:32 PM
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH): That’s How Our Members Made 40% In No Time, Join Us (NASDAQ:AUPH)
www.marketnewscall.com - August 11 at 12:54 PM
streetinsider.com logoForm 6-K Aurinia Pharmaceuticals For: Jun 30 (NASDAQ:AUPH)
www.streetinsider.com - August 5 at 3:40 PM
finance.yahoo.com logoAurinia Pharmaceuticals to Host Lupus Nephritis Expert Breakfast and Webcast on August 4th in New York (NASDAQ:AUPH)
finance.yahoo.com - July 28 at 7:56 PM
finance.yahoo.com logoAurinia Announces Appointment of Head of Communications & Advocacy (NASDAQ:AUPH)
finance.yahoo.com - July 11 at 10:50 AM
seekingalpha.com logoAurinia Pharmaceuticals: Looking Even Better (NASDAQ:AUPH)
seekingalpha.com - July 5 at 8:26 AM
breakingfinancenews.com logoAurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock price target bumped up to $7 as covered today by H.C. Wainwright (NASDAQ:AUPH)
breakingfinancenews.com - July 1 at 11:42 AM

Social

Aurinia Pharmaceuticals (NASDAQ:AUPH) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff